Toni-Claire Miller was 32 when she was repeatedly ‘fobbed off’ by GPs despite numbness in her legs, excruciating back pain and bladder problems.

For years, Sarah Cossar from South Australia lived with constant urgency and pelvic pain, waking up multiple times a night to wee, but she thought she just had a ‘small bladder’. After learning her ...

Urothelial carcinoma is the most common bladder cancer, with stage 1 indicating early-stage disease confined to the bladder lining. Diagnosis involves urinalysis, cystoscopy, TURBT, and imaging to ...

The US Food and Drug Administration has approved Johnson & Johnson’s drug delivery system for a type of bladder cancer, offering a potential surgery-free option for patients. The drug release system, ...

The FDA has approved a gemcitabine intravesical system for Bacillus Calmette-Guérin (BCG)-unresponsive non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS), either with or without ...

Inlexzo is a new treatment for a type of bladder cancer in adults that hasn’t spread to the muscles and doesn’t respond to Bacillus Calmette-Guérin (BCG) therapy. It’s approved for treating non-muscle ...

Sept 10 (Reuters) - The U.S. Food and Drug Administration has approved Johnson & Johnson's (JNJ.N), opens new tab drug delivery system for a type of bladder cancer, offering a potential surgery-free ...

Rian J. Dickstein, MD, provides an overview of detalimogene voraplasmid, currently being evaluated for the treatment of non–muscle invasive bladder cancer. In this interview, Rian J. Dickstein, MD, ...

A patient advocate with overactive bladder talks about how the condition affected her ability to work and the importance of getting treatment. Darlene C. worked as a nurse for nearly three decades.

There’s a new twist in the fight against bladder cancer — and it’s delivering game-changing results. In a recent clinical trial, a pretzel-shaped device that slowly releases chemotherapy drugs ...

Although bladder cancer ranks as the sixth most common cancer in the United States, with approximately 85,000 new cases diagnosed each year, it continues to receive limited awareness, advocacy, and ...

Video content above is prompted by the following: Successful implementation of gene therapy in non-muscle invasive bladder cancer (NMIBC) treatment requires comprehensive institutional protocols ...